← Eichor
Study identifier: NCT06501547 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Association of Leucocyte Telomere Length With DPAS Score in Skin Aging

Condition: Aging · Skin Laxity  ·  Sponsor: Dr.dr.Irma Bernadette, SpKK (K)

PhaseNA
Planned participants20
Who can joinAll sexes, 29 Years to 61 Years
Healthy volunteersYes

About this study

The goal is to know the profile of photoaging based on clinical examination, Dermoscopic Photoaging Scale and leucocyte telomere length The main questions of Research are: * what is the profile of photoaging based on clinical examination results in skin aging * what is the profile of photoaging based on DPAS Score in skin aging * what is the profile of leucocyte telomere length in skin aging Participants are female and male with the age of 29-31 years old and 59-61 years old. They will be examined by dermatovenereologist and will be photographed in 5 positions, they will get dermocopy on forehead, right cheek , left cheek, and chin, and their blood will be drawn about 10 mL in order to get the profile of leucocyte telomere length

This description comes directly from the study's public registry record.

Talk to the study team

Irma Bernadette Sitohang, Prof  ·  +62818130761  ·  irma_bernadette@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Universitas IndonesiaJakarta Pusat, DKI Jakarta, IndonesiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06501547